Back

Exploring evidence for long-standing questions

3 September 2019 (13:20 - 13:40)
Organised by:
Congress Presentation Part of: Improving outcomes with non-vitamin K antagonist oral anticoagulants (NOACs): Focus on atrial fibrillation patients with acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI) Stroke Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Renato Lopes

Duke University Medical Center, Durham (United States of America)

4 More presentations in this session

Presentation thumbnail
Achievements with NOACs in NVAF to date
Professor M. Gilard (Brest, FR)
Slides Video
Presentation thumbnail
NOACs in atrial fibrillation: Current landscape in clinical practice
Professor N. Danchin (Paris, FR)
Slides Video
Presentation thumbnail
Management of atrial fibrillation patients with concomitant need for antiplatelet therapy: Is the dilemma resolved?
Professor P. Sinnaeve (Leuven, BE)
Slides Video
Presentation thumbnail
Questions and answers
Professor M. Gilard (Brest, FR) Professor R. Lopes (Durham, US)
Slides

Access the full session

Session thumbnail
Improving outcomes with non-vitamin K antagonist oral anticoagulants (NOACs): Focus on atrial fibrillation patients with acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI)

The Event

Event poster

ESC Congress 2019

3 September 2019 13:20 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources